Mark Bunker

468 total citations
32 papers, 311 citations indexed

About

Mark Bunker is a scholar working on Surgery, Oncology and Rheumatology. According to data from OpenAlex, Mark Bunker has authored 32 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Oncology and 6 papers in Rheumatology. Recurrent topics in Mark Bunker's work include Immunotherapy and Immune Responses (4 papers), IgG4-Related and Inflammatory Diseases (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Mark Bunker is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), IgG4-Related and Inflammatory Diseases (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Mark Bunker collaborates with scholars based in United States, Canada and Singapore. Mark Bunker's co-authors include M. Vera Peters, Joseph Locker, Jan F. Silverman, Stephen S. Raab, Rodney J. Landreneau, Uma Krishnamurti, Mary Jo Buffo, Haifan Zhang, Mark L. Levitt and Michael R. Shurin and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, The American Journal of Gastroenterology and Stem Cells.

In The Last Decade

Mark Bunker

25 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Bunker United States 11 120 71 60 57 48 32 311
Androutsopoulos Georgios Greece 11 146 1.2× 51 0.7× 38 0.6× 84 1.5× 41 0.9× 93 462
Sang Hyun Hwang South Korea 12 77 0.6× 87 1.2× 52 0.9× 73 1.3× 77 1.6× 36 354
Fredric V. Price United States 15 162 1.4× 99 1.4× 82 1.4× 51 0.9× 89 1.9× 32 677
Ray Lonsdale United Kingdom 11 68 0.6× 78 1.1× 25 0.4× 86 1.5× 34 0.7× 22 306
Ali Cadili Canada 9 106 0.9× 125 1.8× 30 0.5× 61 1.1× 51 1.1× 17 278
Aylin Sar Canada 12 79 0.7× 66 0.9× 46 0.8× 33 0.6× 42 0.9× 23 378
Wayne A. Christopherson United States 13 90 0.8× 118 1.7× 26 0.4× 66 1.2× 49 1.0× 24 474
Azusa Akiyama Japan 10 63 0.5× 37 0.5× 42 0.7× 61 1.1× 31 0.6× 21 262
Hirofumi Tazawa Japan 13 108 0.9× 157 2.2× 53 0.9× 136 2.4× 86 1.8× 55 408
Ghada Khatib United States 9 71 0.6× 70 1.0× 23 0.4× 60 1.1× 45 0.9× 15 244

Countries citing papers authored by Mark Bunker

Since Specialization
Citations

This map shows the geographic impact of Mark Bunker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bunker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bunker more than expected).

Fields of papers citing papers by Mark Bunker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bunker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bunker. The network helps show where Mark Bunker may publish in the future.

Co-authorship network of co-authors of Mark Bunker

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Bunker. A scholar is included among the top collaborators of Mark Bunker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Bunker. Mark Bunker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kirichenko, Alexander, Danny Lee, Seungjong Oh, et al.. (2025). Image-Guided Stereotactic Body Radiotherapy (SBRT) with Enhanced Visualization of Tumor and Hepatic Parenchyma in Patients with Primary and Metastatic Liver Malignancies. Cancers. 17(7). 1088–1088. 1 indexed citations
2.
Bunker, Mark, et al.. (2024). Eosinophilic gastritis in adult complicated by gastric ulcer perforation. Journal of Surgical Case Reports. 2024(3). rjae113–rjae113. 1 indexed citations
4.
Lerner, Lorena, et al.. (2024). Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of Childhood Associated With t(1;22)(p22;q11.2) Mutation. Journal of Hematology. 13(5). 229–237.
5.
Conway, Charles R., Scott Aaronson, Harold A. Sackeïm, et al.. (2023). A Prospective, Multi-center Randomized, Controlled, Blinded Trial of Vagus Verve Stimulation for Difficult to Treat Depression: the RECOVER Trial. Brain stimulation. 16(2). 1–1.
6.
Bunker, Mark, et al.. (2023). S3825 Nodular Regenerative Hyperplasia in a Patient Treated for Triple Positive Breast Cancer. The American Journal of Gastroenterology. 118(10S). S2453–S2453.
7.
Sethi, Ashish, et al.. (2021). Association of Celiac Disease With Pembrolizumab. Cureus. 13(6). e15565–e15565. 9 indexed citations
8.
Bunker, Mark, et al.. (2019). Significance of Crescentic Glomeruli in Acute Kidney Injury with Rheumatoid Arthritis. Case Reports in Nephrology and Dialysis. 9(1). 42–48. 2 indexed citations
9.
Bunker, Mark, et al.. (2019). Fulminant Herpes Simplex Hepatitis Secondary to Adalimumab in Crohn’s Disease: A Case Report. Clinical Medicine Insights Case Reports. 12. 3571489315–3571489315. 3 indexed citations
10.
Uemura, Tadahiro, et al.. (2018). Stereotactic Body Radiation Therapy: A New Strategy for Loco‐Regional Treatment for Hepatocellular Carcinoma While Awaiting Liver Transplantation. World Journal of Surgery. 43(3). 886–893. 16 indexed citations
11.
Monga, Dulabh, et al.. (2016). Primary renal carcinoid tumour with lung metastasis misdiagnosed as renal cell carcinoma. BMJ Case Reports. 2016. bcr2015213432–bcr2015213432. 4 indexed citations
12.
Bunker, Mark, et al.. (2016). GRB7 Expression and Correlation With HER2 Amplification in Invasive Breast Carcinoma. Applied immunohistochemistry & molecular morphology. 25(8). 553–558. 24 indexed citations
13.
Mendicino, Robert W., et al.. (2009). A Diagnosis of Marginal Zone Lymphoma Following Surgical Correction of Hallux Abductovalgus: A Case Report. The Journal of Foot & Ankle Surgery. 48(2). 125–129. 1 indexed citations
14.
Liu, Yulin, Charles D. Sturgis, Mark Bunker, et al.. (2004). Expression of cytokeratin by malignant meningiomas: diagnostic pitfall of cytokeratin to separate malignant meningiomas from metastatic carcinoma. Modern Pathology. 17(9). 1129–1133. 18 indexed citations
15.
Bunker, Mark, Christine Thomas, & Stanley J. Geyer. (2001). Optimizing pretransfusion antibody detection and identification:a parallel, blinded comparison of tube PEG,solid‐phase, and automated methods. Transfusion. 41(5). 621–626. 10 indexed citations
16.
Bunker, Mark, Stephen S. Raab, Rodney J. Landreneau, & Jan F. Silverman. (1999). The Diagnosis and Significance of Visceral Pleural Invasion in Lung Carcinoma: Histologic Predictors and the Role of Elastic Stains. American Journal of Clinical Pathology. 112(6). 777–783. 32 indexed citations
17.
Быковская, С. Н., Mary Jo Buffo, Haifan Zhang, et al.. (1999). The generation of human dendritic and NK cells from hemopoietic progenitors induced by interleukin-15. Journal of Leukocyte Biology. 66(4). 659–666. 23 indexed citations
18.
Bunker, Mark, et al.. (1988). Dermatophilus congolensis and “Hairy” Leukoplakia. American Journal of Clinical Pathology. 89(5). 683–687. 11 indexed citations
19.
Bunker, Mark. (1959). The Terminal Findings in Endometrial Carcinoma. American Journal of Obstetrics and Gynecology. 77(3). 530–538. 10 indexed citations
20.
Bunker, Mark, et al.. (1954). Carcinoma of the body of the uterus. American Journal of Obstetrics and Gynecology. 67(5). 1014–1027. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026